Cargando…

Anti-vascular endothelial growth factor therapy for the treatment of myopic choroidal neovascularization

Myopic choroidal neovascularization (CNV) is a sight-threatening condition which occurs in eyes with myopia, particularly in those with pathologic myopia. It is the most common cause of CNV among patients younger than 50 years. Hemorrhage and exudation from the CNV lesion may eventually result in sc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Colin S, Sadda, SriniVas R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627729/ https://www.ncbi.nlm.nih.gov/pubmed/29026284 http://dx.doi.org/10.2147/OPTH.S124518

Ejemplares similares

Real-World Anti-Vascular Endothelial Growth Factor Therapy Outcomes in Myopic Choroidal Neovascularization
por: Bhatia, Devangna, et al.
Publicado: (2021)

Characteristics and response of subretinal hyperreflective material to anti-vascular endothelial growth factor in myopic choroidal neovascularization
por: Huang, Chien-Jung, et al.
Publicado: (2023)

Long-term follow-up of perifoveal exudative vascular anomalous complex treated with intravitreal injections of anti-vascular endothelial growth factor and thermal laser photocoagulation
por: Corvi, Federico, et al.
Publicado: (2020)

Baseline predictors for good visual gains after anti-vascular endothelial growth factor therapy for myopic choroidal neovascularization
por: Hsu, Cherng-Ru, et al.
Publicado: (2022)

Response of Pediatric Choroidal Neovascularization to Anti-Vascular Endothelial Growth Factor
por: Ruparelia, Sunil, et al.
Publicado: (2021)

Results of Intravitreal Anti-Vascular Endothelial Growth Factor Therapy in Inflammatory Choroidal Neovascularization
por: Zina, Sourour, et al.
Publicado: (2021)

Neovascular Age-Related Macular Degeneration (nAMD): A Review of Emerging Treatment Options
por: Tan, Colin S, et al.
Publicado: (2022)

Optical Coherence Tomography Angiography-Based Quantitative Assessment of Morphologic Changes in Active Myopic Choroidal Neovascularization During Anti-vascular Endothelial Growth Factor Therapy
por: Wang, Yao, et al.
Publicado: (2021)

Evaluation of efficacy and recurrence for anti-vascular endothelial growth factor therapy in idiopathic choroidal neovascularization
por: Wu, Qianru, et al.
Publicado: (2020)

Anti-vascular endothelial growth factors for choroidal neovascularization secondary to choroidal osteoma: Long-term results
por: Lekha, T., et al.
Publicado: (2015)

Morphological parameters of myopic choroidal neovascularization as predictive factors of anti-VEGF treatment response
por: Castellino, Niccolò, et al.
Publicado: (2022)

Management of Neovascular Age-Related Macular Degeneration during the COVID-19 Pandemic
por: Corradetti, Giulia, et al.
Publicado: (2020)

A CONSENSUS ON RISK MITIGATION FOR BROLUCIZUMAB IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Patient Selection, Evaluation, and Treatment
por: Holz, Frank G., et al.
Publicado: (2022)

Type 3 macular neovascularization in a patient with pentosan polysulfate maculopathy
por: Bousquet, Elodie, et al.
Publicado: (2022)

Surgical choroidal neovascular membrane removal in the era of anti-vascular endothelial growth factor agents
por: Nagpal, Manish, et al.
Publicado: (2009)

Autofluorescence findings and role of anti-vascular endothelial growth factor in inflammatory choroidal neovascular membrane
por: Chhablani, Jay Kumar
Publicado: (2010)

Single intravitreal ranibizumab for myopic choroidal neovascularization
por: Nor-Masniwati, Saidin, et al.
Publicado: (2011)

Current and emerging treatment options for myopic choroidal neovascularization
por: El Matri, Leila, et al.
Publicado: (2015)

Spectral domain-optical coherence tomography retinal biomarkers in choroidal neovascularization of multifocal choroiditis, myopic choroidal neovascularization, and idiopathic choroidal neovascularization
por: Gao, Rui, et al.
Publicado: (2021)

Risk factors for myopic choroidal neovascularization-related macular atrophy after anti-VEGF treatment
por: Bae, Ki Woong, et al.
Publicado: (2022)

Profiling neovascular age‐related macular degeneration choroidal neovascularization lesion response to anti‐vascular endothelial growth factor therapy using SSOCTA
por: Told, Reinhard, et al.
Publicado: (2020)

Evaluation of the Choroid in Women with Uncomplicated Pregnancy
por: Su, Li, et al.
Publicado: (2020)

Association between choriocapillaris flow deficit and choroidal neovascularization activity in eyes with myopic choroidal neovascularization
por: Uematsu, Sato, et al.
Publicado: (2021)

Paediatric choroidal neovascular membrane secondary to toxoplasmosis treated successfully with anti-vascular endothelial growth factor
por: Mathur, Gaurav, et al.
Publicado: (2014)

Anti-vascular endothelial growth factor treatment regimens preference by choroidal neovascularization patients under COVID-19
por: Au, Sunny Chi Lik
Publicado: (2020)

Meticulous multimodal analysis of aflibercept therapy for submacular vascularized pigment epithelial detachment associated with neovascular AMD in a prospective case series, the EVEN study
por: Chan, Clement K., et al.
Publicado: (2020)

Combined photodynamic therapy and intravitreal bevacizumab as treatment for nonresponsive myopic choroidal neovascularization
por: Chhablani, Jay Kumar
Publicado: (2010)

Multimodal imaging and diagnosis of myopic choroidal neovascularization in Caucasians
por: Milani, Paolo, et al.
Publicado: (2016)

Result of intravitreal aflibercept injection for myopic choroidal neovascularization
por: Chen, Shih-Lin, et al.
Publicado: (2021)

Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
por: Wang, Jia-Kang, et al.
Publicado: (2018)

Relapse of choroidal neovascularization in Bietti's crystalline retinopathy following anti-vascular endothelial growth factor therapy: A case report
por: HUA, RUI, et al.
Publicado: (2015)

Inflammatory choroidal neovascularization in Indian eyes: Etiology, clinical features, and outcomes to anti-vascular endothelial growth factor
por: Roy, Rupak, et al.
Publicado: (2017)

Interactions between Endostatin and Vascular Endothelial Growth Factor (VEGF) and Inhibition of Choroidal Neovascularization
por: Wang, Xun, et al.
Publicado: (2007)

Wide-field angiography in retinal vein occlusions
por: Tan, Colin S., et al.
Publicado: (2019)

Ultra-Widefield Indocyanine Green Angiography Reveals Patterns of Choroidal Venous Insufficiency Influencing Pachychoroid Disease
por: Bacci, Tommaso, et al.
Publicado: (2022)

Relationship Between Drusen Height and OCT Biomarkers of Atrophy in Non-Neovascular AMD
por: Au, Adrian, et al.
Publicado: (2022)

Prediction of Visual Acuity in Pathologic Myopia with Myopic Choroidal Neovascularization Treated with Anti-Vascular Endothelial Growth Factor Using a Deep Neural Network Based on Optical Coherence Tomography Images
por: Yang, Migyeong, et al.
Publicado: (2023)

Vascular endothelial growth factor inhibitors for predominantly Caucasian myopic choroidal neovascularization: 2‐year treatment outcomes in clinical practice: data from the Fight Retinal Blindness! Registry
por: Gabrielle, Pierre‐Henry, et al.
Publicado: (2021)

Anti-VEGF treatment for myopic choroid neovascularization: from molecular characterization to update on clinical application
por: Zhang, Yan, et al.
Publicado: (2015)

Treatment of myopic choroidal neovascularization with intravitreal ranibizumab injections: the role of age
por: Karagiannis, Dimitrios, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_fjra5l0hvl4ss9lomnoutdc8q9